MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$13,192K
EPS
-$0.09
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
9,941 4,266* 10,085 9,389
General and administrative
4,971 3,604* 3,831 4,333
Total operating expenses
14,912 7,870 13,916 13,722
Loss from operations
-14,912 -7,870* -13,916 -13,722
Interest income, net
1,696 1,275* 2,101 1,407
Other income (expense), net
4 -17* -2 -7
Interest expense
-0* 0 0
Total other income, net
1,700 1,257* 2,099 1,400
Loss before income taxes
-13,212 -6,614* -11,817 -12,322
Income tax benefit
-20 -10* -15 -21
Net loss
-13,192 -6,604 -11,802 -12,301
Basic EPS
-0.09 -0.051 -0.08 -0.09
Diluted EPS
-0.09 -0.051 -0.08 -0.09
Basic Average Shares
145,592,901 128,786,217 145,104,986 130,350,391
Diluted Average Shares
145,592,901 128,786,217 145,104,986 130,350,391
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$13,192K Income tax benefit-$20K Interest income, net$1,696K Other income(expense), net$4K Loss before incometaxes-$13,212K Total other income,net$1,700K Loss from operations-$14,912K Total operatingexpenses$14,912K Research and development$9,941K General andadministrative$4,971K

Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics, Inc. (TRVI)